Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of tretinoin + clindamycin phosphate gel in adolescents with acne vulgaris
2010-022912-37Phase 3
- Sponsor
- Medicis Pharmaceutical
- Start
- Mar 2012
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clindamycin + tretinoin in acne vulgaris, sponsored by Medicis Pharmaceutical. Primary endpoint: Safety - overall adverse event experience.
02
Drugs
clindamycin + tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2010-022912-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022912-37.